Pricing Log in Create free account

Novogen Limited (KZIA) vs vTv Therapeutics Inc. (VTVT)

Novogen Limited and vTv Therapeutics Inc. are both Biotechnology companies. Novogen Limited and vTv Therapeutics Inc. are of similar size ($95.0M and $92.4M). Across the 10 metrics below, Novogen Limited leads on 7 and vTv Therapeutics Inc. on 3.

Valuation

Metric KZIA VTVT Biotechnology median
P/E n/m n/m 10.26
P/S — 7.15 9.18
P/B n/m 3.44 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA 1.46 n/m 0.65
EV/Sales n/m 4.90 8.98
Earnings yield (3.03%) (3.53%) (34.89%)
Free cash flow yield 0.00% (6.23%) (24.52%)

Profitability

Metric KZIA VTVT Biotechnology median
Gross margin 0.00% 99.92% 65.16%
Operating margin — 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (11.74%) (50.12%)
Return on assets 0.00% (8.34%) (45.60%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric KZIA VTVT Biotechnology median
Revenue growth (TTM) — 654.58% 6.26%
EPS growth (last fiscal year) 63.24% 0.00% 29.88%
Revenue growth, 5-year CAGR 11.56% (39.39%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric KZIA VTVT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.87 12.48 4.89
Net debt to EBITDA 0.30 2.71 1.01

Dividend

Metric KZIA VTVT Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric KZIA VTVT Biotechnology median
Market cap 92.35m 95.02m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack